These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33932262)

  • 1. Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first-in-human clinical trial.
    Málek F; Gajewski P; Zymliński R; Janczak D; Chabowski M; Fudim M; Martinca T; Neužil P; Biegus J; Mates M; Krüger A; Skalský I; Bapna A; Engelman ZJ; Ponikowski PP
    Eur J Heart Fail; 2021 Jul; 23(7):1134-1143. PubMed ID: 33932262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort.
    Fudim M; Fail PS; Litwin SE; Shaburishvili T; Goyal P; Hummel SL; Borlaug BA; Mohan RC; Patel RB; Mitter SS; Klein L; Rocha-Singh K; Patel MR; Reddy VY; Burkhoff D; Shah SJ
    Eur J Heart Fail; 2022 Aug; 24(8):1410-1414. PubMed ID: 35598154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transvenous Right Greater Splanchnic Nerve Ablation in Heart Failure and Preserved Ejection Fraction: First-in-Human Study.
    Fudim M; Zirakashvili T; Shaburishvili N; Shaishmelashvili G; Sievert H; Sievert K; Reddy VY; Engelman ZJ; Burkhoff D; Shaburishvili T; Shah SJ
    JACC Heart Fail; 2022 Oct; 10(10):744-752. PubMed ID: 36175060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial.
    Fudim M; Litwin SE; Borlaug BA; Mohan RC; Price MJ; Fail P; Zirakashvili T; Shaburishvili T; Goyal P; Hummel SL; Patel RB; Reddy VY; Burkhoff D; Patel MR; Somo SI; Shah SJ
    J Card Fail; 2024 Jul; 30(7):877-889. PubMed ID: 38211934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Hemodynamic Changes following Surgical Ablation of the Right Greater Splanchnic Nerve for the Treatment of Heart Failure with Preserved Ejection Fraction.
    Gajewski P; Fudim M; Kittipibul V; Engelman ZJ; Biegus J; Zymliński R; Ponikowski P
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF.
    Sugumar H; Nanayakkara S; Vizi D; Wright L; Chieng D; Leet A; Mariani JA; Voskoboinik A; Prabhu S; Taylor AJ; Kalman JM; Kistler PM; Kaye DM; Ling LH
    Eur J Heart Fail; 2021 May; 23(5):785-796. PubMed ID: 33565197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.
    Chieng D; Sugumar H; Segan L; Tan C; Vizi D; Nanayakkara S; Al-Kaisey A; Hawson J; Prabhu S; Voskoboinik A; Finch S; Morton JB; Lee G; Mariani J; La Gerche A; Taylor AJ; Howden E; Kistler PM; Kalman JM; Kaye DM; Ling LH
    JACC Heart Fail; 2023 Jun; 11(6):646-658. PubMed ID: 36868916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
    Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: The ALT FLOW Early Feasibility Study 1-year results.
    Urey MA; Hibbert B; Jorde U; Eckman P; Simard T; Labinaz M; Nazer B; Wiley M; Gupta B; Sauer A; Shah H; Sorajja P; Pineda AM; Missov E; Mahmud E; Kahwash R; Lilly S; Latib A; Murthy S; Fam N; Garcia S; Chung ES; Klein L; Cheng R; Houston BA; Amoroso NS; Chang L; Gafoor S; Chaudhry SP; Hermiller J; Schwartz JG; Aldaia L; Koulogiannis K; Gray WA; Zahr F
    Eur J Heart Fail; 2024 Apr; 26(4):1065-1077. PubMed ID: 38606485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
    Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
    JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
    Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
    JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
    Borlaug BA; Reddy YNV; Braun A; Sorimachi H; Omar M; Popovic D; Alogna A; Jensen MD; Carter R
    Circulation; 2023 Sep; 148(10):834-844. PubMed ID: 37534453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.
    Fudim M; Borlaug BA; Mohan RC; Price MJ; Fail P; Goyal P; Hummel SL; Zirakashvili T; Shaburishvili T; Patel RB; Reddy VY; Nielsen CD; Chetcuti SJ; Sukul D; Gulati R; Kim L; Benzuly K; Mitter SS; Klein L; Uriel N; Augostini RS; Blair JE; Rocha-Singh K; Burkhoff D; Patel MR; Somo SI; Litwin SE; Shah SJ
    JAMA Cardiol; 2024 Oct; ():. PubMed ID: 39356530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure.
    Eisman AS; Shah RV; Dhakal BP; Pappagianopoulos PP; Wooster L; Bailey C; Cunningham TF; Hardin KM; Baggish AL; Ho JE; Malhotra R; Lewis GD
    Circ Heart Fail; 2018 May; 11(5):e004750. PubMed ID: 29695381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splanchnic Nerve Block for Chronic Heart Failure.
    Fudim M; Boortz-Marx RL; Ganesh A; DeVore AD; Patel CB; Rogers JG; Coburn A; Johnson I; Paul A; Coyne BJ; Rao SV; Gutierrez JA; Kiefer TL; Kong DF; Green CL; Jones WS; Felker GM; Hernandez AF; Patel MR
    JACC Heart Fail; 2020 Sep; 8(9):742-752. PubMed ID: 32535123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction.
    Dorfs S; Zeh W; Hochholzer W; Jander N; Kienzle RP; Pieske B; Neumann FJ
    Eur Heart J; 2014 Nov; 35(44):3103-12. PubMed ID: 25161181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
    Litwin SE; Komtebedde J; Seidler T; Borlaug BA; Winkler S; Solomon SD; Eicher JC; Mazimba S; Khawash R; Sverdlov AL; Hummel SL; Bugger H; Boenner F; Hoendermis E; Cikes M; Demers C; Silva G; van Empel V; Starling RC; Penicka M; Cutlip DE; Leon MB; Kitzman DW; van Veldhuisen DJ; Shah SJ;
    Eur J Heart Fail; 2024 Jan; 26(1):177-189. PubMed ID: 37989800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.